Aligos Therapeutics (ALGS) Current Deferred Revenue (2020 - 2025)
Aligos Therapeutics (ALGS) posted Current Deferred Revenue of $168,000 for Q3 2025, down 74.4% from $655,000 a year earlier and down 71.0% from the prior quarter.
Aligos Therapeutics (ALGS) Current Deferred Revenue (2020 - 2025) Analysis & Trends
At the end of FY2024, Aligos Therapeutics' Current Deferred Revenue came in at $151,000, down 88.5% from FY2023.
- Annual Current Deferred Revenue shows a four-year compound annual growth rate of -62.8% (FY2020 to FY2024).
- In prior years, Aligos Therapeutics' Current Deferred Revenue was $1.31 million in FY2023 (-85.0%), $8.74 million in FY2022 (+14.4%), $7.64 million in FY2021 (-3.2%) and $7.89 million in FY2020.
- Quarterly Current Deferred Revenue has run from a low of $151,000 in Q4 2024 to a high of $15.07 million in Q1 2022 over five years.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q1 2022, with growth of 98.7%; the weakest was Q1 2024, with a decline of 89.0%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 579,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Sep 30, 2024 | 655,000.00 |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 721,000.00 |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 2.09 Mn |
| Jun 30, 2023 | 4.10 Mn |
| Mar 31, 2023 | 6.56 Mn |
| Dec 31, 2022 | 8.74 Mn |
| Sep 30, 2022 | 10.73 Mn |
| Jun 30, 2022 | 13.13 Mn |
| Mar 31, 2022 | 15.07 Mn |
| Dec 31, 2021 | 7.64 Mn |
| Sep 30, 2021 | 6.64 Mn |
| Jun 30, 2021 | 6.81 Mn |
| Mar 31, 2021 | 7.58 Mn |
| Dec 31, 2020 | 7.89 Mn |
Aligos Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();